GP14

1. GP14 decreases telomere length in silico (β -0.020, 95% CI -0.037 to -0.002).

   “and LTL (β -0.020, 95% CI -0.037 to -0.002, p = 0.029) in the two-sample MR analysis.”

   In silico

   The Causality between Human Immunoglobulin G (IgG) N-Glycosylation and Aging: A Mendelian Randomization Study

   Molecules (Basel, Switzerland)·14 Mar 2024

More on Telomere length

1. GP14 increases frailty in silico (β 0.026, 95% CI 0.003 to 0.050).

   “found suggestive evidence of a causal association between GP14 and FI (β 0.026, 95% CI 0.003 to 0.050, p = 0.027)”

   In silico

   The Causality between Human Immunoglobulin G (IgG) N-Glycosylation and Aging: A Mendelian Randomization Study

   Molecules (Basel, Switzerland)·14 Mar 2024